Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novartis shares climb after drug maker says it may sell small assets
Marketwatch
Tuesday, October 22, 2013 - 12:49pm
tags:
Novartis
The Next Best Big Pharma?
Seeking Alpha
Tuesday, October 22, 2013 - 11:57am
tags:
Regeneron
Fresh burst of biotech IPO pitches launches a busy Q4 season
Fierce Biotech
Tuesday, October 22, 2013 - 11:51am
tags:
IPOs, Foundation Medicine, Ophthotech, Intrexon, Onconova, Agios, OncoMed
Novartis grabs an option to buy biotech startup for up to $300M
Fierce Biotech
Tuesday, October 22, 2013 - 11:43am
tags:
M&A, Novartis, SP-420, Sideris Pharmaceuticals
Reckitt Benckiser reviews pharma unit, could sell it
Yahoo/Reuters
Tuesday, October 22, 2013 - 11:31am
tags:
Reckitt Benckiser, M&A, Suboxone
Amgen acquires Filgrastim franchise rights from Roche
Yahoo/Fly on the Wall
Tuesday, October 22, 2013 - 11:28am
tags:
Roch, filgrastim, Amgen, pegfilgrastim
Whisper Number: What Will Amgen’s Shares Do Post-Earnings?
Wall St. Cheat Sheet
Tuesday, October 22, 2013 - 11:24am
tags:
Amgen, earnings
J&J-Medivir’s Drug Works Against Hepatitis C
Bloomberg
Tuesday, October 22, 2013 - 8:36am
tags:
JNJ, Medivir, hepatitis C, simeprevir, FDA
Problems Found With Insmed's Analysis of Arikace Cystic Fibrosis Study
TheStreet.com
Tuesday, October 22, 2013 - 8:30am
tags:
Insmed, Arikace, cystic fibrosis
Forest quarterly earnings beat analyst expectations
Yahoo/Reuters
Tuesday, October 22, 2013 - 8:17am
tags:
earnings, Forest Labs
Evotec, AstraZeneca in Kidney Disease Alliance
Contract Pharma
Tuesday, October 22, 2013 - 8:16am
tags:
kidney disease, AstraZeneca, Evotec
Roche's Avastin boosts survival in advanced ovarian cancer
Pharma Times, UK
Tuesday, October 22, 2013 - 8:15am
tags:
Roche, ovarian cancer, Avastin
Lilly's Pipeline Fears Are Overblown
TheStreet.com
Tuesday, October 22, 2013 - 8:14am
tags:
Eli Lilly, Merck, Pfizer, patent cliff
Novartis Raises 2013 Forecast on Lack of Diovan Generic
Bloomberg
Tuesday, October 22, 2013 - 8:11am
tags:
Novartis, guidance, Diovan
Health-Care False Claims Cases Reap $18.3 Billion, Report
Bloomberg
Tuesday, October 22, 2013 - 8:10am
tags:
whistleblower lawsuits, False Claims Act
Illumina reports eighth beat in a row, raises profit forecast
Yahoo/Reuters
Tuesday, October 22, 2013 - 8:08am
tags:
earnings, Illumina
Medivation, Astellas prostate cancer drug meets trial goals
Yahoo/Reuters
Tuesday, October 22, 2013 - 8:07am
tags:
Medivation, prostate cancer, Astellas, Enzalutamide
Novartis advances rival CDK 4/6 cancer drug to Pfizer's palbociclib
Fierce Biotech
Monday, October 21, 2013 - 5:55pm
tags:
Novartis, cyclin-dependent kinase inhibition [CDK], Pfizer, palbociclib, LEE011
Depomed Sells Type 2 Diabetes Royalties And Milestones To PDL BioPharma For $240.5 Million
Yahoo
Monday, October 21, 2013 - 5:51pm
tags:
diabetes, Depomed, PDL Biopharma
Will Celgene's (CELG) Earnings Streak End?
Yahoo/Zacks
Monday, October 21, 2013 - 5:50pm
tags:
Celgene, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.